ArticleBMC cancer2024

Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy.

Lin Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.